Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8 GBX | -1.23% | -1.23% | -71.43% |
Business Summary
Number of employees: 45
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biomarker Research and Development
62.0
%
| 0 | 100.0 % | 0 | 62.0 % | +105.19% |
Proprietary Products
38.0
%
| - | - | 0 | 38.0 % | - |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
76.1
%
| 0 | 69.5 % | 0 | 76.1 % | +262.62% |
Rest of World
23.9
%
| 0 | 30.5 % | 0 | 23.9 % | +159.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 62 | 07-04-22 | |
Jon Burrows
CEO | Chief Executive Officer | - | 20-03-22 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 17-09-14 |
Thomas Guiel
COO | Chief Operating Officer | - | - |
Bipin Patel
LAW | General Counsel | - | 19-12-31 |
Bartu Ahiska
PRN | Corporate Officer/Principal | - | 19-06-12 |
Ewan Hunter
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Diggle
BRD | Director/Board Member | 60 | 16-10-03 |
David Holbrook
BRD | Director/Board Member | 63 | 19-04-04 |
Jon Burrows
CEO | Chief Executive Officer | - | 20-03-22 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 17-09-14 |
Founder | 62 | 07-04-22 | |
Chairman | 65 | 20-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 311,855,650 | 252,932,158 ( 81.11 %) | 0 | 81.11 % |
Company contact information
Oxford BioDynamics Plc
3140 Rowan Place John Smith Drive
OX4 2WB, Oxford
+44 1865 518 910
http://www.oxfordbiodynamics.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-71.43% | 20.31M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- OBD Stock
- Company Oxford BioDynamics Plc